Search

everythinglearnresearchcommunity

for

Search:↓

A woman's vitiligo improved with tofacitinib treatment, and her skin color remained even after stopping the medication, but there are concerns about cancer risk.

Anti-CD19 therapy may help treat SLE and NMOSD.

Proactive monitoring and management are essential to maximize the benefits of Trastuzumab Deruxtecan while minimizing serious side effects.

Eculizumab helps reduce blood transfusions and stabilize hemoglobin but increases infection risk and is expensive.

Ixekizumab has known and some unexpected side effects.

Sintilimab treatment caused hair loss but led to complete tumor remission.

Tofacitinib significantly improved symptoms in a patient with overlapping autoimmune disorders.

The new skin-targeted COVID-19 vaccine creates strong immune responses and could improve vaccination methods.

The FDA approved the first gene therapy for a blood disorder after overcoming early challenges and demonstrating patient benefits.

Canagliflozin helps overcome progestin resistance in certain endometrial cancer cells.

A cancer patient died from a severe skin reaction after taking the drug cetuximab.

New inhibitors may reduce gut toxicity from cancer drugs.

Combining DEB-BACE with chemotherapy is more effective and has fewer side effects than chemotherapy alone for treating unresectable lung squamous cell carcinoma.

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

Agaricus bisporus β-Glucan particles could effectively treat cervical cancer and offer antimicrobial and antioxidant benefits.

Janus Kinase inhibitors are effective and have an acceptable safety profile for treating moderate to severe Ulcerative Colitis.

Tofacitinib effectively treated a woman's complex autoimmune and autoinflammatory disorders.

Docetaxel slightly extends prostate cancer survival but has significant side effects and high cost.

Guselkumab effectively reduces fatigue in Psoriatic Arthritis patients over two years.

Tofacitinib significantly improved hair loss and lesions in a patient with overlapping autoimmune disorders.

Enfortumab vedotin can cause skin issues, especially in older males, needing early monitoring.

Telitacicept effectively improved hair regrowth in a woman with lupus and alopecia.

Combining Ficlatuzumab and Gefitinib can cause severe hair loss.

Tocilizumab might be an effective treatment for COVID-19.

Guselkumab significantly improves psoriasis symptoms within 12 weeks.

BI 2536 had limited effectiveness against several advanced cancers and caused significant side effects.

Kanglaite injection with chemotherapy improves treatment and reduces side effects for advanced lung cancer.

Tofacitinib helps improve skin conditions in people with Down syndrome, especially alopecia areata.

A woman with severe angioedema improved significantly after treatment with rituximab.